{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:55:52Z","timestamp":1791910552639,"version":"4.3.4"},"reference-count":88,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,12,26]]},"abstract":"<jats:p>A deep dive into genomic aberrations in 37 new diagnoses of primary mediastinal B-cell lymphoma (PMBL) reveals a surprisingly high number of driver mutations as well as genetic and epigenetic explanations for immune evasion by the tumor.<\/jats:p>","DOI":"10.1182\/blood.2019002067","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T16:02:16Z","timestamp":1572278536000},"page":"2369-2382","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":97,"title":["Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6485-8773","authenticated-orcid":false,"given":"Bjoern","family":"Chapuy","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"},{"name":"Department of Hematology and Oncology, University Medical Center G\u00f6ttingen, G\u00f6ttingen, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-9552","authenticated-orcid":false,"given":"Chip","family":"Stewart","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6152-3169","authenticated-orcid":false,"given":"Andrew J.","family":"Dunford","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaegil","family":"Kim","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9548-4420","authenticated-orcid":false,"given":"Kirsty","family":"Wienand","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atanas","family":"Kamburov","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel K.","family":"Griffin","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Hsuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Lako","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1329-5288","authenticated-orcid":false,"given":"Robert A.","family":"Redd","sequence":"additional","affiliation":[{"name":"Department of Data Sciences and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire M.","family":"Cote","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Ducar","sequence":"additional","affiliation":[{"name":"Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron R.","family":"Thorner","sequence":"additional","affiliation":[{"name":"Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1761-9769","authenticated-orcid":false,"given":"Scott J.","family":"Rodig","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0936-0753","authenticated-orcid":false,"given":"Gad","family":"Getz","sequence":"additional","affiliation":[{"name":"Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA;"},{"name":"Department of Pathology and"},{"name":"Center for Cancer Research, Massachusetts General Hospital, Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3949-6897","authenticated-orcid":false,"given":"Margaret A.","family":"Shipp","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"20","key":"2019122611532075900_B1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"2019122611532075900_B2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00705408","article-title":"Primary mediastinal clear cell lymphoma of B-cell type","volume":"409","author":"M\u00f6ller","year":"1986","journal-title":"Virchows Arch A Pathol Anat Histopathol"},{"issue":"3","key":"2019122611532075900_B3","first-page":"411","article-title":"The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression","volume":"59","author":"M\u00f6ller","year":"1986","journal-title":"Immunology"},{"issue":"4","key":"2019122611532075900_B4","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V69.4.1087.1087","article-title":"Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation","volume":"69","author":"M\u00f6ller","year":"1987","journal-title":"Blood"},{"issue":"12","key":"2019122611532075900_B5","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"issue":"4","key":"2019122611532075900_B6","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood-2004-12-4901","article-title":"NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes","volume":"106","author":"Feuerhake","year":"2005","journal-title":"Blood"},{"issue":"6","key":"2019122611532075900_B7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"issue":"7","key":"2019122611532075900_B8","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1097\/00000478-199607000-00012","article-title":"Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (\u201cGroupe d\u2019Etude des Lymphomes de l\u2019Adulte\u201d) study","volume":"20","author":"Cazals-Hatem","year":"1996","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2019122611532075900_B9","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","article-title":"Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene","volume":"87","author":"Joos","year":"1996","journal-title":"Blood"},{"issue":"5","key":"2019122611532075900_B10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","article-title":"TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma","volume":"206","author":"Schmitz","year":"2009","journal-title":"J Exp Med"},{"issue":"23","key":"2019122611532075900_B11","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1182\/blood-2016-03-704528","article-title":"Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma","volume":"128","author":"Mansouri","year":"2016","journal-title":"Blood"},{"issue":"4","key":"2019122611532075900_B12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.2900","article-title":"Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma","volume":"46","author":"Gunawardana","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"2019122611532075900_B13","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1182\/blood-2009-03-209759","article-title":"Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma","volume":"114","author":"Ritz","year":"2009","journal-title":"Blood"},{"issue":"18","key":"2019122611532075900_B14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1182\/blood-2017-09-808907","article-title":"Somatic IL4R mutations in primary mediastinal large B-cell lymphoma lead to constitutive JAK-STAT signaling activation","volume":"131","author":"Vigan\u00f2","year":"2018","journal-title":"Blood"},{"issue":"17","key":"2019122611532075900_B15","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2010-05-282780","article-title":"Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma","volume":"116","author":"Green","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019122611532075900_B16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ccr.2010.11.013","article-title":"Cooperative epigenetic modulation by cancer amplicon genes","volume":"18","author":"Rui","year":"2010","journal-title":"Cancer Cell"},{"issue":"10","key":"2019122611532075900_B17","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1078-0432.CCR-13-3007","article-title":"Selective JAK2 inhibition specifically decreases Hodgkin lymphoma and mediastinal large B-cell lymphoma growth in vitro and in vivo","volume":"20","author":"Hao","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2019122611532075900_B18","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","article-title":"Targetable genetic features of primary testicular and primary central nervous system lymphomas","volume":"127","author":"Chapuy","year":"2016","journal-title":"Blood"},{"issue":"6","key":"2019122611532075900_B19","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1078-0432.CCR-11-1942","article-title":"Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy","volume":"18","author":"Green","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"13","key":"2019122611532075900_B20","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"issue":"7338","key":"2019122611532075900_B21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"7","key":"2019122611532075900_B22","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","article-title":"Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC class II expression","volume":"13","author":"Mottok","year":"2015","journal-title":"Cell Reports"},{"issue":"1","key":"2019122611532075900_B23","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","article-title":"Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival","volume":"108","author":"Roberts","year":"2006","journal-title":"Blood"},{"issue":"36","key":"2019122611532075900_B24","doi-asserted-by":"crossref","first-page":"13520","DOI":"10.1073\/pnas.0804295105","article-title":"Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways","volume":"105","author":"Lenz","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"2019122611532075900_B25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1182\/blood-2018-04-791566","article-title":"How I treat primary mediastinal B-cell lymphoma","volume":"132","author":"Giulino-Roth","year":"2018","journal-title":"Blood"},{"issue":"15","key":"2019122611532075900_B26","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"2019122611532075900_B27","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1182\/blood-2016-12-758383","article-title":"Safety and tolerability of pembrolizumab in patients with relapsed\/refractory primary mediastinal large B-cell lymphoma","volume":"130","author":"Zinzani","year":"2017","journal-title":"Blood"},{"issue":"23","key":"2019122611532075900_B28","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.1182\/bloodadvances.2019001012","article-title":"Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion","volume":"3","author":"Wienand","year":"2019","journal-title":"Blood Adv"},{"issue":"10","key":"2019122611532075900_B29","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2019122611532075900_B30","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","article-title":"Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes","volume":"24","author":"Chapuy","year":"2018","journal-title":"Nat Med"},{"issue":"18","key":"2019122611532075900_B31","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/bioinformatics\/btr446","article-title":"ContEst: estimating cross-contamination of human samples in next-generation sequencing data","volume":"27","author":"Cibulskis","year":"2011","journal-title":"Bioinformatics"},{"issue":"3","key":"2019122611532075900_B32","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1093\/nar\/gku1211","article-title":"BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers","volume":"43","author":"Abo","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2019122611532075900_B33","doi-asserted-by":"crossref","first-page":"R84","DOI":"10.1186\/gb-2014-15-6-r84","article-title":"LUMPY: a probabilistic framework for structural variant discovery","volume":"15","author":"Layer","year":"2014","journal-title":"Genome Biol"},{"issue":"7333","key":"2019122611532075900_B34","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature09744","article-title":"The genomic complexity of primary human prostate cancer","volume":"470","author":"Berger","year":"2011","journal-title":"Nature"},{"issue":"4","key":"2019122611532075900_B35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1101\/gr.221028.117","article-title":"SvABA: genome-wide detection of structural variants and indels by local assembly","volume":"28","author":"Wala","year":"2018","journal-title":"Genome Res"},{"issue":"2","key":"2019122611532075900_B36","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1101\/gr.141382.112","article-title":"Somatic rearrangements across cancer reveal classes of samples with distinct patterns of DNA breakage and rearrangement-induced hypermutability","volume":"23","author":"Drier","year":"2013","journal-title":"Genome Res"},{"issue":"5","key":"2019122611532075900_B37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nbt.2203","article-title":"Absolute quantification of somatic DNA alterations in human cancer","volume":"30","author":"Carter","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"7457","key":"2019122611532075900_B38","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"4","key":"2019122611532075900_B39","doi-asserted-by":"crossref","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","article-title":"GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers","volume":"12","author":"Mermel","year":"2011","journal-title":"Genome Biol"},{"issue":"3","key":"2019122611532075900_B40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"40","key":"2019122611532075900_B41","doi-asserted-by":"crossref","first-page":"E5486","DOI":"10.1073\/pnas.1516373112","article-title":"Comprehensive assessment of cancer missense mutation clustering in protein structures","volume":"112","author":"Kamburov","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"39","key":"2019122611532075900_B42","doi-asserted-by":"crossref","first-page":"41566","DOI":"10.18632\/oncotarget.5893","article-title":"The dark side of ZNF217, a key regulator of tumorigenesis with powerful biomarker value","volume":"6","author":"Cohen","year":"2015","journal-title":"Oncotarget"},{"issue":"6","key":"2019122611532075900_B43","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.ccr.2011.11.006","article-title":"Combined genetic inactivation of \u03b22-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma","volume":"20","author":"Challa-Malladi","year":"2011","journal-title":"Cancer Cell"},{"issue":"7530","key":"2019122611532075900_B44","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/nature13765","article-title":"Loss of signalling via G\u03b113 in germinal centre B-cell-derived lymphoma","volume":"516","author":"Muppidi","year":"2014","journal-title":"Nature"},{"issue":"2","key":"2019122611532075900_B45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/ng.518","article-title":"Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin","volume":"42","author":"Morin","year":"2010","journal-title":"Nat Genet"},{"issue":"4","key":"2019122611532075900_B46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood-2014-06-582650","article-title":"Activating STAT6 mutations in follicular lymphoma","volume":"125","author":"Yildiz","year":"2015","journal-title":"Blood"},{"issue":"9","key":"2019122611532075900_B47","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"7360","key":"2019122611532075900_B48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"3","key":"2019122611532075900_B49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ccr.2012.07.014","article-title":"Integrative analysis reveals an outcome-associated and targetable pattern of p53 and cell cycle deregulation in diffuse large B cell lymphoma","volume":"22","author":"Monti","year":"2012","journal-title":"Cancer Cell"},{"issue":"43","key":"2019122611532075900_B50","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2019122611532075900_B51","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1182\/blood-2011-05-326538","article-title":"The molecular pathogenesis of primary mediastinal large B-cell lymphoma","volume":"118","author":"Steidl","year":"2011","journal-title":"Blood"},{"issue":"9","key":"2019122611532075900_B52","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/leu.2016.95","article-title":"Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia","volume":"30","author":"Watanabe-Smith","year":"2016","journal-title":"Leukemia"},{"issue":"6297","key":"2019122611532075900_B53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.aae0477","article-title":"Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity","volume":"353","author":"Dorand","year":"2016","journal-title":"Science"},{"issue":"3","key":"2019122611532075900_B54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/JLB.MR1218-507R","article-title":"IRF2BP2: A new player in the regulation of cell homeostasis","volume":"106","author":"Ramalho-Oliveira","year":"2019","journal-title":"J Leukoc Biol"},{"key":"2019122611532075900_B55","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cellsig.2018.02.016","article-title":"STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma","volume":"46","author":"Miloudi","year":"2018","journal-title":"Cell Signal"},{"issue":"1","key":"2019122611532075900_B56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13045-017-0412-4","article-title":"XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy","volume":"10","author":"Camus","year":"2017","journal-title":"J Hematol Oncol"},{"issue":"9","key":"2019122611532075900_B57","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/ajh.24451","article-title":"Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma","volume":"91","author":"Jardin","year":"2016","journal-title":"Am J Hematol"},{"issue":"7","key":"2019122611532075900_B58","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1182\/blood-2013-02-483727","article-title":"Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing","volume":"122","author":"Morin","year":"2013","journal-title":"Blood"},{"issue":"2","key":"2019122611532075900_B59","first-page":"333","article-title":"Amplification of zinc finger gene 217 (ZNF217) and cancer: when good fingers go bad","volume":"1775","author":"Quinlan","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"2019122611532075900_B60","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev.cellbio.24.110707.175347","article-title":"Regulation of MHC class I assembly and peptide binding","volume":"24","author":"Peaper","year":"2008","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"7","key":"2019122611532075900_B61","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2014-11-610436","article-title":"Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells","volume":"125","author":"Reichel","year":"2015","journal-title":"Blood"},{"issue":"12","key":"2019122611532075900_B62","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1158\/1078-0432.CCR-15-2305","article-title":"Next-generation sequencing in diffuse large B-cell lymphoma highlights molecular divergence and therapeutic opportunities: a LYSA study","volume":"22","author":"Dubois","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2019122611532075900_B63","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3557","article-title":"Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors","volume":"48","author":"Kim","year":"2016","journal-title":"Nat Genet"},{"issue":"4","key":"2019122611532075900_B64","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamaoncol.2018.5801","article-title":"Analysis of the prevalence of microsatellite instability in prostate cancer and response to immune checkpoint blockade","volume":"5","author":"Abida","year":"2019","journal-title":"JAMA Oncol"},{"issue":"10","key":"2019122611532075900_B65","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/s41379-019-0289-6","article-title":"Colorectal carcinoma with double somatic mismatch repair gene inactivation: clinical and pathological characteristics and response to immune checkpoint blockade","volume":"32","author":"Wang","year":"2019","journal-title":"Mod Pathol"},{"issue":"1","key":"2019122611532075900_B66","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","article-title":"The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints","volume":"5","author":"Llosa","year":"2015","journal-title":"Cancer Discov"},{"issue":"9","key":"2019122611532075900_B67","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S1470-2045(17)30422-9","article-title":"Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study","volume":"18","author":"Overman","year":"2017","journal-title":"Lancet Oncol"},{"issue":"22","key":"2019122611532075900_B68","doi-asserted-by":"crossref","first-page":"6486","DOI":"10.1158\/0008-5472.CAN-18-1814","article-title":"Commutations in DNA damage response pathways serve as potential biomarkers for immune checkpoint blockade","volume":"78","author":"Wang","year":"2018","journal-title":"Cancer Res"},{"issue":"29","key":"2019122611532075900_B69","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1038\/s41388-018-0245-9","article-title":"APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"issue":"1","key":"2019122611532075900_B70","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.1038\/ncomms6129","article-title":"A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3\u2019UTR enhances chromosomal DNA damage","volume":"5","author":"Caval","year":"2014","journal-title":"Nat Commun"},{"issue":"5","key":"2019122611532075900_B71","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ng.2955","article-title":"Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer","volume":"46","author":"Nik-Zainal","year":"2014","journal-title":"Nat Genet"},{"issue":"12","key":"2019122611532075900_B72","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/PAS.0000000000000297","article-title":"Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain","volume":"38","author":"Shi","year":"2014","journal-title":"Am J Surg Pathol"},{"issue":"7607","key":"2019122611532075900_B73","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2032-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"issue":"6","key":"2019122611532075900_B74","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ccr.2013.11.003","article-title":"Discovery and characterization of super-enhancer-associated dependencies in diffuse large B cell lymphoma","volume":"24","author":"Chapuy","year":"2013","journal-title":"Cancer Cell"},{"issue":"52","key":"2019122611532075900_B75","doi-asserted-by":"crossref","first-page":"20014","DOI":"10.1074\/jbc.RA118.005796","article-title":"The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK\/Jun kinase pathway","volume":"293","author":"Li","year":"2018","journal-title":"J Biol Chem"},{"issue":"4","key":"2019122611532075900_B76","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1158\/2159-8290.CD-18-1090","article-title":"Molecular and genetic characterization of MHC deficiency identifies EZH2 as therapeutic target for enhancing immune recognition","volume":"9","author":"Ennishi","year":"2019","journal-title":"Cancer Discov"},{"issue":"11","key":"2019122611532075900_B77","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1158\/2326-6066.CIR-16-0201","article-title":"Classical Hodgkin lymphoma with reduced \u03b22M\/MHC class I expression is associated with inferior outcome independent of 9p24.1 status","volume":"4","author":"Roemer","year":"2016","journal-title":"Cancer Immunol Res"},{"issue":"10","key":"2019122611532075900_B78","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1200\/JCO.2017.77.3994","article-title":"Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma","volume":"36","author":"Roemer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"22","key":"2019122611532075900_B79","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1182\/blood-2017-03-770719","article-title":"Topological analysis reveals a PD-L1-associated microenvironmental niche for Reed-Sternberg cells in Hodgkin lymphoma","volume":"130","author":"Carey","year":"2017","journal-title":"Blood"},{"issue":"1","key":"2019122611532075900_B80","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41590-017-0004-z","article-title":"Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy","volume":"19","author":"Barkal","year":"2018","journal-title":"Nat Immunol"},{"issue":"1","key":"2019122611532075900_B81","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41590-017-0009-7","article-title":"Another way to not get eaten","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat Immunol"},{"issue":"10","key":"2019122611532075900_B82","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"issue":"7463","key":"2019122611532075900_B83","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"26","key":"2019122611532075900_B84","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa1500596","article-title":"PD-1 blockade in tumors with mismatch-repair deficiency","volume":"372","author":"Le","year":"2015","journal-title":"N Engl J Med"},{"issue":"5","key":"2019122611532075900_B85","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"issue":"269","key":"2019122611532075900_B86","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"issue":"6","key":"2019122611532075900_B87","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00439-015-1542-9","article-title":"Characterization of 14 novel deletions underlying Rubinstein-Taybi syndrome: an update of the CREBBP deletion repertoire","volume":"134","author":"Rusconi","year":"2015","journal-title":"Hum Genet"},{"issue":"9","key":"2019122611532075900_B88","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1101\/gr.092759.109","article-title":"Circos: an information aesthetic for comparative genomics","volume":"19","author":"Krzywinski","year":"2009","journal-title":"Genome Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/26\/2369\/1549702\/bloodbld2019002067.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/26\/2369\/1549702\/bloodbld2019002067.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,26]],"date-time":"2021-01-26T06:31:51Z","timestamp":1611642711000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/26\/2369\/422650\/Genomic-analyses-of-PMBL-reveal-new-drivers-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,26]]},"references-count":88,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2019,12,26]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019002067","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,26]]}}}